Противоопухолевое действие нового производного дигидроакридина на экспериментальной модели рака мочевого пузыря

Екатерина Блинова(Sechenov University), К. К. Арутюнян, А. А. Махрова, М. Ю. Кудрявцев, Е. А. Самышина, О. М. Тумутолова(National Research Mordovia State University), Ю. С. Гилевская, С. Я. Скачилова, О. Н. Дерябина, А. А. Епишкина(Sechenov University), Д. С. Блинов(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology)
Экспериментальная и клиническая фармакология
October 5, 2022
10.30906/0869-2092-2022-85-9-22-26
Cited by 0

Related Papers

Therapeutic Potential and Main Methods of Obtaining Selenium Nanoparticles
|International Journal of Molecular Sciences|2021|85
Patient-Derived Non-Muscular Invasive Bladder Cancer Xenografts of Main Molecular Subtypes of the Tumor for Anti-Pd-l1 Treatment Assessment
|Cells|2019|19
Novel Hydroxypyridine Compound Protects Brain Cells against Ischemic Damage In Vitro and In Vivo
|International Journal of Molecular Sciences|2022|16
Novel aminochromone derivative inhibits tumor growth on xenograft model of lung cancer in mice
|Journal of Advanced Pharmaceutical Technology amp Research|2018|14
Prognostic Role of FGFR3 Expression Status and Tumor-Related MicroRNAs Level in Association with PD-L1 Expression in Primary Luminal Non-Muscular Invasive Bladder Carcinoma
|Life|2020|13